PFIZER
|
The Current P/S Ratio of PFIZER is 8.70.
| Share Price | ₹4,523.4 | Feb 01,2026 |
| Market Cap | ₹20,671.9 Cr | |
| Sales-TTM | ₹2,375.3 Cr | TTM-Standalone Results |
| Price/Sales | 8.70x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of PFIZER
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹20,671.9 Cr] as on Feb 01,2026
(/) Sales [ ₹2,375.3 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 8.70x ]
Thus, for PFIZER , the investors are currently willing to pay '8.70 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PFIZER !
The chart below summarizes the trend in P/S Ratio of PFIZER over the last five years.
Historical PS (Price/Sales) ratio chart of PFIZER
PS Ratio Performance Analysis for PFIZER
- PFIZER 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 8.04x.
- PFIZER 's operated at median p/e ratio of 8.03x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PFIZER 's p/e ratio peaked in Mar2021 at 9.24x.
- PFIZER 's p/e ratio hit its five-year low in Mar2023 of 6.54x.
How does PFIZER 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| PFIZER | 2,375.3 | 8.70 | 20,671.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 6.80 | 386,341.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 15.99 | 160,401.0 |
| CIPLA LTD | 28,351.1 | 3.78 | 107,100.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.04 | 135,175.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.85 | 98,715.9 |
| MANKIND PHARMA LTD | 13,576.9 | 6.36 | 86,402.2 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.61 | 88,427.8 |
| LUPIN LTD | 24,750.7 | 3.95 | 97,729.5 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.09 | 67,889.9 |
| ABBOTT INDIA LTD | 6,714.4 | 8.64 | 58,021.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PFIZER 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.09x |
| Max industry PS | 15.99x |
| Median industry PS | 6.36x |
| Average industry PS | 6.71x |
You may also like the below Video Courses